Please login to the form below

Not currently logged in
Email:
Password:

AZ to develop partnership prospects

AstraZeneca has appointed Katja Toon as communications director, externalisation, to lead the pharmaceutical company's dealings with other firms and organisations

Katja Toon
Katja Toon

AstraZeneca (AZ) has appointed Katja Toon as communications director, externalisation, to lead the pharmaceutical company's dealings with other firms and organisations.

Reporting to Neil McCrae, vice-president of group corporate communications, Toon's newly created role will see her raise the profile of AZ with regards to in-licensing, acquisitions and opportunities for partnership.

In a statement, AZ has said its goal is to become "the partner of choice with academic and industry audiences".

Toon has 15 years of international experience in healthcare communications, including her most recent position at M:Communications.

Prior to this role, she co-founded and was director of Northbank Communications, a specialist life sciences consultancy that was acquired by College Hill in October 2007.

Commenting on her appointment, Toon said: "AstraZeneca already has an excellent track record in innovation and commercialisation of pharmaceuticals and I am looking forward to helping the company to achieve its externalisation objectives including that of becoming the partner of choice amongst industry audiences."

5th September 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics